1. Home
  2. STTK vs ISTR Comparison

STTK vs ISTR Comparison

Compare STTK & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.98

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$26.85

Market Cap

268.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ISTR
Founded
2016
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
268.9M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
STTK
ISTR
Price
$3.98
$26.85
Analyst Decision
Buy
Buy
Analyst Count
5
1
Target Price
$4.00
$29.00
AVG Volume (30 Days)
469.9K
47.5K
Earning Date
11-06-2025
01-22-2026
Dividend Yield
N/A
1.64%
EPS Growth
N/A
24.14
EPS
N/A
2.22
Revenue
$1,000,000.00
$93,426,000.00
Revenue This Year
N/A
$7.18
Revenue Next Year
N/A
$70.45
P/E Ratio
N/A
$12.05
Revenue Growth
N/A
12.93
52 Week Low
$0.69
$15.39
52 Week High
$4.00
$27.95

Technical Indicators

Market Signals
Indicator
STTK
ISTR
Relative Strength Index (RSI) 83.32 56.29
Support Level $3.15 $26.16
Resistance Level $3.29 $27.25
Average True Range (ATR) 0.23 0.52
MACD 0.05 -0.20
Stochastic Oscillator 91.26 33.52

Price Performance

Historical Comparison
STTK
ISTR

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: